MESANGIOPROLIFERATIVE GLOMERULONEPHRITIS WITH IgM DEPOSITION: CLINICAL CHARACTERISTICS AND OUTCOME

REFERENCES

• Cohen A H, Border W A, Glassock R J. Nephrotic syndrome with Glomerular mesangial IgM deposits. Lab Invest 1978; 38: 610–619
   PubMed Web of Science ®Google Scholar
• O'Donoghue D J, Lawler W, Hunt L P, Acheson E J, Mallick N P. IgM-associated primary diffuse mesangial proliferative glomerulonephritis: Natural history and prognostic indicators. Q J Med 1991; 79: 333–350
   PubMedGoogle Scholar
• Cavallo T, Johnson M P. Immunopathologic study of minimal change glomerular disease with mesangial IgM deposits. Nephron 1984; 27: 281–284
   Google Scholar
• del Moral R G, Gomez-Morales M, Cortes V, et al. Mononuclear cell subsets in IgM mesangial proliferative glomerulonephritis. Nephron 1993; 65: 215–221
   PubMed Web of Science ®Google Scholar
• Hishiki T, Tomino Y, Inokuchi S, et al. Two adult cases of IgM-associated mesangial proliferative glomerulonephritis. Nippon Jinzo Gakkai Shi 1994; 36: 942–946
   PubMedGoogle Scholar
• Bhasin H K, Abuelo G, Nayak R F, Esparza A. Mesangial proliferative glomerulonephritis. Lab Invest 1978; 39: 21–29
   PubMed Web of Science ®Google Scholar
• Hall C. Does IgM nephropathy exist?. Presented at Society of DGH Nephrologists. 21 Nov 1997
   Google Scholar
• Tejani A, Nicastri A D. Mesangial IgM nephropathy. Nephron 1983; 35: 1–5
   PubMed Web of Science ®Google Scholar
• Saha H, Mustonen J, Pasternack A, Helin H. Clinical follow-up of 54 patients with IgM nephropathy. Am J Nephrol 1989; 9: 124–128
   PubMed Web of Science ®Google Scholar
• Ji-Yun Y, Melvin T, Sibley R, Michael A F. No evidence for a specific role of IgM in mesangial proliferation of idiopathic nephrotic syndrome. Kidney Int 1984; 25: 100–106
   PubMed Web of Science ®Google Scholar
• International Study of Kidney disease in children: Primary nephrotic syndrome in children: clinical significance of histopathologic variants of minimal change and of diffuse mesangial hypercellularity. Kidney Int 1981; 20: 765–71
   PubMed Web of Science ®Google Scholar
• Al-Eisa A, Carter J E, Lirenman D S, Magil A B. Childhood IgM Nephropathy: Comparison with Minimal change disease. Nephron 1996; 72: 37–43
   PubMed Web of Science ®Google Scholar
• Southwest Pediatric Study Group: Childhood nephrotic syndrome associated with diffuse mesangial hypercellularity. Kidney Int 1983; 23: 87–94
   Google Scholar
• Lin J-T, Lin C-Y, Huang F-U, Lee P-P, Chen C-H, Hsu H-C. A clinicopathological study of idiopathic nephrotic syndrome in children. Nippon Jinzo Gakkai Shi 1995; 37: 442–450
   PubMedGoogle Scholar
• Hsu H C, Chen W Y, Lin G J, Chen L, Kao S-L, Huang C-C. Clinical and immunopathological study of mesangial IgM nephropathy: report of 41 cases. Histopathology 1984; 8: 435–446
   PubMed Web of Science ®Google Scholar
• Vilches A R, Turner D R, Cameron J S, Ogg C S, Chantler C, Williams D G. Significance of mesangial IgM deposition in “minimal change nephrotic syndrome”. Lab Invest 1982; 46: 10–15
   PubMed Web of Science ®Google Scholar
• Pardo V, Riesgo I, Zilleruelo G, Strauss J. The clinical significance of mesangial IgM deposits and mesangial hypercellularity in minimal change nephrotic syndrome. Am J Kidney Dis 1984; 3: 264–269
   PubMed Web of Science ®Google Scholar
• Gonzalo A, Mampaso F, Gallego N, Querada C, Fierro C, Ortuno J. Clinical significance of IgM mesangial deposits in the nephrotic syndrome. Nephron 1985; 41: 246–249
   PubMed Web of Science ®Google Scholar
• Looi L M, Wang F, Lam K L, Chua C T. Mesangial IgM in minimal change glomerular disease: A clinicopathological study in a Malaysian population. Pathology 1985; 17: 41–44
   PubMed Web of Science ®Google Scholar
• Hirszel P, Yamase H T, Carney W R, et al. Mesangial proliferative glomerulonephritis with IgM deposits: clinicopathologic analysis and evidence for morphologic transition. Nephron 1984; 38: 100–108
   PubMed Web of Science ®Google Scholar
• Michael A F, Nevins T E, Raij L, Keane W F, Scheinman J I. Macromolecular transport in the glomerulus: studies of the mesangium and epithelium in vivo and in vitro. Immunologic mechanisms of renal disease. Churchill, Livingstone, New york 1979; 167–213
   Google Scholar
• Kobayashi Y, Shigematsu H, Tgateno S, Hiki Y. Nephrotic syndrome with diffuse mesangial IgM deposits. Acta Pathol Jpn 1982; 32: 307–317
   PubMedGoogle Scholar
• Sharma M, Sharma R, McCarthy E T, Savin V J. “The FSGS factor”: enrichment and in vivo effect of activity from focal segmental glomerulosclerosis plasma. J Am Soc Nephrol 1999; 10: 552–561
   PubMed Web of Science ®Google Scholar
• Feld S M, Figueroa P, Savin V, et al. Plasmapheresis in the treatment of steroid-resistant focal segmental glomerulosclerosis in native kidneys. Am J Kidney Dis 1998; 32: 230–237
   PubMed Web of Science ®Google Scholar